https://www.business-standard.com/health/biocon-biologics-launches-biosimilar-alternative-to-stelara-in-the-us-125022400897_1.html
YESINTEK is approved for Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis, offering a cost-effective treatment for chronic...
biocon biologicslaunchesbiosimilaralternativestelara
https://www.pharmacytimes.com/view/fda-approves-selarsdi-as-biosimlar-to-stelara-in-an-intravenous-formulation
In April 2024, the FDA approved ustekinumab-aekn as a subcutaneous injection for the treatment of moderate to severe plaque psoriasis and active psoriatic...
fdaselarsdistelaraintravenous